Advertising prescription-only medicines to the public is illegal in the UK. The MHRA, the Advertising Standards Authority and the General Pharmaceutical Council have issued joint reminders of this, specifically in the context of weight-loss medicines.
Every weight-loss injection and every weight-loss GLP-1 tablet licensed in the UK is prescription-only. So none of them can be advertised to you.
What That Rules Out
The ASA's position covers far more than the brand names. Indirect references count as advertising the medicine, including:
- Phrases such as "weight loss injections", "weight loss pen", "obesity treatment jab" and "GLP-1"
- "Skinny jab" and similar coinages, because consumers understand them to mean an injectable weight-loss medicine
- Images of unbranded injection pens, partial images of pens, and vials of liquid
This is why the marketing you actually see is so oblique — silhouettes, before-and-after framing, "start your journey", talk of "treatment plans" and "clinical programmes" without ever naming what is in them.
Why the Rule Exists
The reasoning is that a prescription-only medicine is prescription-only because someone with clinical training needs to decide whether it suits you. Advertising creates demand for a specific product before that assessment happens, which inverts the process.
ASA consumer research found that many people viewed weight-loss ads as encouraging a purchase rather than a medical consultation, and did not know that weight-loss injections are prescription-only in the first place.
What This Means When You Are Comparing
Three practical consequences.
1. Marketing tells you almost nothing useful
A provider legally cannot tell you which medicine, at which strength, for what price, in an advert aimed at the public. So the advert is competing on tone and imagery, and none of that correlates with what you will pay.
2. The information exists — after you engage
Prices and product details can be given to a person who has started a consultation. That is why you often cannot see a price until you have entered details, and it is a legal constraint rather than a dark pattern in every case.
3. Comparison has to be built from prices, not adverts
Which is the whole reason a site like this exists: to assemble what providers actually charge at each strength, rather than reproducing what they are allowed to say about themselves.
Compliance Has Improved
The ASA has run targeted enforcement on paid online ads for weight-loss prescription medicines, and reported compliance improving to very high levels over the period it monitored. So the oblique advertising you see now is largely the compliant version. Ads that do name the medicine are a signal worth noticing — either the seller does not know the rules, or is not troubled by them.
A Related Rule
The GPhC has also warned pharmacies against promoting prescription weight-loss medicines, and its guidance says pharmacy owners cannot incentivise prescribers to issue prescriptions. If a service feels built to get you to a "yes", that is the standard it is being measured against.